US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Gatifloxacin Ophthalmic Solution 0.5%

Reason Labeling: Missing label; Product complaints reported missing bottle label.

Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-1490-2019
Class III · Low risk Terminated

Smart Sense Regular Strength Aspirin Tablets

Reason Labeling; Incorrect or Missing Lot Number and/or Exp Date; Product has an incorrect expiration date of 9/2022 applied to the labeling, where the actual expiration date is 10/2021.

AAA Pharmaceutical, Inc. D-1585-2019
Class III · Low risk Terminated

Lotemax

Reason Failed Stability Specifications: Out of specification for viscosity.

Bausch & Lomb NDC 24208-503-07 D-1396-2019
Class III · Low risk Terminated

Myorisan

Reason Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.

Akorn Inc NDC 61748-304-13 D-1392-2019
Class III · Low risk Terminated

Ondansetron Injection

Reason Failed Impurities/Degradation Specifications.

Fresenius Kabi USA, LLC NDC 63323-374-20 D-1386-2019
Class III · Low risk Terminated

QUIK-CARE Aerosol Foam Hand Sanitizer

Reason Incorrect/undeclared excipients: Hand sanitizer was made using the wrong alcohol raw material.

Ecolab Inc NDC 47593-490-82 D-1393-2019
Class III · Low risk Terminated

Relpax

Reason Labeling: Label Error on Declared Strength: an artwork error on the secondary packaging of Relpax 40 mg Tablets, indicates that each tablet contains eletriptan hydrobromide equivalent to 20mg eletriptan, instead of 40mg, on one side of the carton.

Pfizer Inc. NDC 0049-2340-05 D-1278-2019
Class III · Low risk Terminated

Dermoplast Anesthetic PAIN & ITCH

Reason Labeling: Not Elsewhere Classified: Full cases may contain canisters that incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.

Advantice Health D-1280-2019
Class III · Low risk Terminated

Dermoplast Anesthetic PAIN & ITCH

Reason Labeling: Not Elsewhere Classified: canisters incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.

Advantice Health D-1279-2019
Class III · Low risk Terminated

Fentanyl Citrate Injection

Reason Failed impurities/degradation specification: Out of Specification result for total impurity at 4.0% (Limit: NMT 3.0%) at 12 months stability testing.

Akorn Inc NDC 17478-030-25 D-1241-2019
Class III · Low risk Terminated

Carvedilol Tablets

Reason Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.

Zydus Pharmaceuticals USA Inc NDC 68382-092-05 D-1242-2019
Class III · Low risk Terminated

Telmisartan and Amlodipine Tablets 80 mg/5 mg

Reason Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer)

AVKARE Inc. NDC 42291-795-30 D-1122-2019
Class III · Low risk Terminated

Lemon Hand Sanitizer

Reason CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.

NingBo Huize Commodity Co.,Ltd. D-1564-2019